Xponance, Inc.

SEC CIK: 0001637541
Latest filing: Aug 10, 2026

SEC filings (opens in a new tab)

LCTX holding history

Lineage Cell Therapeutics, Inc. in every 13F filed by Xponance, Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

LCTX overview All 13F holders of LCTX Full Q2 2026 holdings

Shares (Q2 2026): 17,522
Value: $23.0K
% of portfolio: <0.1%
Quarters held: 3; Since Q4 2024

Holdings of LCTX by Xponance, Inc., by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q2 2026	17,522	$23.0K	<0.1%	+17,522	New	Holders
Q2 2025	0	$0	0.0%	−12,875−100.0%	Sold out	Holders
Q1 2025	12,875	$5.81K	<0.1%	+2,419+23.1%	Added	Holders
Q4 2024	10,456	$5.25K	<0.1%	+10,456	New	Holders